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Abstract
Background: Pre-mRNA splicing occurs mainly co-transcriptionally, and both nucleosome density and histone
modifications have been proposed to play a role in splice site recognition and regulation. However, the extent and
mechanisms behind this interplay remain poorly understood.
Results: We use transcriptomic and epigenomic data generated by the ENCODE project to investigate the
association between chromatin structure and alternative splicing. We find a strong and significant positive
association between H3K9ac, H3K27ac, H3K4me3, epigenetic marks characteristic of active promoters, and exon
inclusion in a small but well-defined class of exons, representing approximately 4 % of all regulated exons. These
exons are systematically maintained at comparatively low levels of inclusion across cell types, but their inclusion is
significantly enhanced in particular cell types when in physical proximity to active promoters.
Conclusion: Histone modifications and other chromatin features that activate transcription can be co-opted to
participate in the regulation of the splicing of exons that are in physical proximity to promoter regions.
Keywords: Chromatin, Splicing, Histone, Modifications, Promoters, Proximity, Transcription, Epigenetic, RNA,
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Background
Alternative pre-mRNA splicing is assumed to expand
the diversity of mRNAs encoded in the genome. The
prevalence of alternative splicing increases from inverte-
brates to vertebrates [1] and is particularly high in the
immune and nervous systems, where high diversity of
molecular repertoires is necessary for cell identity [2].
Whether an alternative exon is included or excluded in a
mature RNA is considered a matter of combinatorial
control, involving splice sites, additional binding sites,
and the factors that recognize them [3]. Recent evidence
suggests that chromatin organization and transcriptional
dynamics may also contribute to this control. First, spli-
cing can occur co-transcriptionally [4, 5], and this has
been demonstrated to be widespread in yeast [6], fruit
fly [7], and human [8, 9]. Second, some splicing factors
are known to interact with modified histone tails, and
intragenic histone modifications have been shown to be
involved in alternative splicing decisions on individual
genes [10]. Third, RNA Polymerase II elongation dynam-
ics is known to influence exon inclusion [11, 12], which
was shown to be modulated by CTCF binding [13].
Lastly, a number of independent studies demonstrated
that nucleosome density correlates with exon-intron
architecture genome-wide [9, 14–19], and specifically
with exon inclusion levels [20, 21].
While links between chromatin and splicing have thus
been established, attempts to incorporate chromatin infor-
mation on quantitative models predictive of cell type-
specific exon inclusion levels have met so far with moder-
ate success [22], and the extent to which cell type-specific
chromatin organization contributes to cell type-specific
splicing patterns remain largely unknown.
Here to investigate the relationship between chromatin
and splicing, we analyzed transcriptome and epigenome
data generated in a number of human cell lines within
the ENCODE project [23, 24]. First, we used RNASeq
data to identify exons that are differentially included be-
tween cell lines. We found that a relatively small fraction
of human exons (about 3 % of all internal exons in about
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10 % of all investigated genes) exhibit regulated inclu-
sion across human cell lines. These regulated exons are
maintained at intermediate inclusion levels compared to
all exons. Second, we used ChIPSeq data to investigate
the association between the inclusion of regulated exons
and histone modifications. Our results strongly suggest
that there is little or no direct association between his-
tone modifications and the inclusion levels of the major-
ity of these exons. We identified, however, a small set of
regulated exons (about 4 % of all differentially included
exons) in which cell type-specific inclusion levels do ap-
pear to be directly associated to levels of canonically ac-
tivating histone modifications. In contrast to most
exons, the inclusion of these exons is maintained at re-
markable low levels across a large variety of cell types
and tissues. In addition to being enriched in histone
modifications, these exons have other characteristics
typical of promoter regions, but they do not correspond
to sites of transcription initiation. However, they tend to
lie closer to transcription initiation sites, and through
chromatin looping they tend to interact with promoter
regions.
Our observations are consistent with a role for pro-
moter regions and for promoter-characteristic epigenetic
signatures in the regulation of the alternative splicing of
a well-defined set of exons, possibly involving the open-
ing of chromatin and folding of chromatin loops that
bring together regulated exons and promoters into close
spatial distance. Histone modifications and other fea-
tures that activate transcription could then be co-opted
in these cases to participate also in the regulation of
exon inclusion.
Results
R1. Alternatively included exons in pair-wise cell type
comparisons
We used nuclear polyA+ RNASeq samples from five
Tier 1 human cell lines from the ENCODE project
(K562, Gm12878, Hepg2, Huvec, Helas3) [25] to identify
differentially included internal exons in pair-wise com-
parisons of cell lines. We used a method similar to that
published by Wang et al. [26] (Fig. 1a, Methods, Add-
itional file 1: Figure S1). Nuclear polyA+ RNA was se-
lected, since, in contrast to other RNA fractions, in this
fraction splicing has been essentially completed [9], but
it is unlikely to have undergone nonsense mediated
decay (NMD), and thus, it reflects more precisely the
direct outcome of splicing.
We selected 73,329 internal exons with canonical
splice junctions that lay at least 600 bp away from the
closely annotated Transcription Start Site (TSS) and
Transcription Termination Site (TTS), and for which
there were enough RNASeq reads to compute differen-
tial inclusion in at least one pairwise cell comparison
(see Methods). These belong to 15,679 different genes.
We used the one-sided Fisher test on the number of ex-
clusion and inclusion reads to identify differentially in-
cluded exons between each cell pair (see Methods).
Exons with significant inclusion level changes were
called more/less included exons depending in the direc-
tion of the change (Fig. 1a). Figure 1b–g shows the re-
sults of the comparison of Gm12878 and K562. We
identified 1,688 exons regulated between these two cell
lines (1,066 more included in Gm12878 and 622 more
included in K562, P value <0.05, Fig. 1b). These differen-
tially included exons possess known properties of alter-
native exons, as previously described in the literature
[27, 28]: (1) they have weaker splice sites compared to
exons not differentially included (Fig. 1c); (2) they tend
to be shorter (Fig. 1d); and (3) when coding, their length
is more often divisible by three (Fig. 1e). Moreover, (4)
we did not find significant differences in the expression
levels of the genes hosting differentially included exons
between the two cell lines compared (Fig. 1f ). In order
to independently validate our alternative exon calling
method, we selected a total of 15 of these exons (Fig. 1g).
Using exon-junction oligonucleotides (Additional file 1:
Table S1), we quantified by qPCR the ratio of inclusion/
skipping isoform in Gm12878 compared to K562. This
method of quantification provides an assessment of the
differences in the relative inclusion of the exons regard-
less of possible differences in gene expression between
the cell lines compared. We validated 12 out of the 15
selected cases (Fig. 1g), corresponding to a validation
rate of 80 %.
We assessed whether conditions 1–4 above (Fig. 1c–f )
were satisfied in each of the 10 pairwise comparisons be-
tween the five cell lines considered here, and we kept
only the seven comparisons satisfying all of them (Add-
itional file 1: Table S2). Furthermore, we retained only
exons with minimum absolute change of 0.1 or two-fold
in the inclusion levels between the two cell lines. In
total, we obtained 1,849 more included and 2,483 less
included exon comparisons in the seven cell-pairs
employed. The terms ‘more included exons’ and ‘less in-
cluded exons’ are arbitrary, since they depend on the dir-
ection of the comparison. We preferred to keep them
separate to allow for better visualization and validation
of the results presented (see below).
Because the same exon can appear in different pair-
wise comparisons, when pooled together, the two sets
correspond to 2,081 unique exons that showed regulated
inclusion levels across the human ENCODE cell lines.
These correspond to about 3 % of all exons initially con-
sidered, and belong to 1,637 genes (10.44 % of all genes
initially considered). Exons with regulated inclusion ex-
hibit in general weak inclusion changes across human
cell lines (Fig. 2a). The median exon inclusion range
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(that is, the differences between the maximum and mini-
mum inclusion observed) is 0.20. For more than 90 % of
the exons, the change is less than 0.5. Moreover, they
show generally intermediate exon inclusion levels when
compared with the inclusion levels of non-regulated
exons (Fig. 2b).
Because gene expression levels are linked to chromatin
organization [29] and can also influence splicing [3],
we excluded exons from genes showing large (more
than 10-fold) expression differences between cell lines.
In addition, in our analysis, we used only one exon per
gene, the one with the lowest P value. In total, we ob-
tained 1,684 more included and 2,198 less included
exon comparisons in the seven cell pairs employed cor-
responding to 1,921 unique exons (Additional file 1:
Table S3, Additional files 2 and 3). The splicing land-
scape of this filtered set of regulated exons is very simi-
lar to the previous one (Fig. 2 and Additional file 1:
Figure S2).
R2. Co-occurrence of differences in histone modifications
with alternative exon inclusion
For each differentially included exon in each pairwise
cell comparison, we computed differential signal for nine
histone marks, the insulator protein CTCF and input
DNA [24, 30, 31]. We defined the ‘differential signal’ for
each chromatin feature as the difference of the averaged
normalized signal over the exon in the second cell type
(for example, Gm12878 for the comparison K562 vs.
Gm12878) and the averaged normalized signal over the
exon in the first one (for example, K562 for the same
comparison, see Methods). We pooled the differential
exonic signal across all exons and all cell-line compari-
sons together to produce a single composite comparison
for each monitored variable separately for ‘more in-
cluded’ and ‘less included’ exons. By using differential
signals on the same genomic interval, we eliminated
possible biases due to intrinsic genomic features such as
GC content.
Fig. 1 Assessment and properties of exons differentially spliced between cell lines K562 and Gm12878. a Classification of ‘more included’ and
‘less included’ exons. b Estimated inclusion ratio in the K562 cell line (x-axis) and in the Gm12878 cell line (y-axis) of exons whose inclusion is:
(1) significantly higher in Gm12878 (dark blue); (2) significantly higher in the K562 cell line (dark red); (3) whose inclusion does not change
significantly between the two cell lines (light blue). c Distribution of the sum of the strengths of 5’ and 3’ splice sites flanking exons that do not
display significant differences in inclusion between the cell lines (notAS, left boxplot) and differentially included (that is, regulated) exons (AS,
right boxplot). Wilcoxon rank-sum tests were calculated for the two distributions, significance levels are indicated: * (0.05 > P > 0.01), ** (0.01 > P > 0.001),
*** (0.001 > P). d Exon length distribution of AS and notAS exons. e Fraction of AS and notAS exons, the length of which is multiple of three: only exons
that were entirely coding were considered. f Expression of genes with exons whose inclusion is: (1) significantly higher in Gm12878 (dark blue);
(2) significantly higher in the K562 cell line (dark red). X-axis: log2 (TSS-HMM value) in K562; Y-axis: log2 (TSS-HMM value) in Gm12878. g Experimental
validation: comparison between inclusion levels of differentially regulated exons between Gm12878 and K562, calculated analyzing RNASeq ENCODE
data (gray bars) or with RT-qPCR analyses of RNA extracted from K562 and Gm12878 (green bars). For RT-qPCR analysis were used primers amplifying
specifically the inclusion or skipping isoform. Gray bars represent log2 ratio of inclusion level between Gm12878 and K562 calculated for each exon
form RNASeq. Green bars represent log2 ratio between inclusion/skipping ratio in Gm12878 and K562, normalized to the ratio in a constitutive exon
on the same transcript; error bars represent standard deviations of three independent experiments. Twelve out of 15 exons tested show consistent
inclusion direction as measured by RNASeq and RT-qPCR
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Our analysis revealed enrichment of CTCF, H3K9ac,
H3K27ac, and H3K4me3 levels in more included exons
(P value <0.01; Wilcoxon signed-rank test with Bonfer-
roni correction) (Fig. 3a). We also observed a negative
association with the control signal, which consists of
cross-linked and sonicated DNA. This may represent a
measure of chromatin compaction, and may reflect an
association between open chromatin and higher levels of
exon inclusion. Importantly, the association observed
between exon inclusion and input DNA is in the oppos-
ite direction than that observed for rest of the chromatin
features, indicating that we are likely underestimating
the strength of the associations. To validate these re-
sults, we performed ChIP-qPCR using H3K9ac anti-
bodies and primers specific (Additional file 1: Table S4)
for the target exons (and a constitutive exon of the same
gene as a control) in K562 and Gm12878 cells. In all
four alternative exons investigated, a clear difference in
H3K9ac signal between the two cell lines was detected,
positively correlating with differential exon usage. In
contrast, constitutive exons on the same genes showed,
in general, smaller (sometimes even opposite) differences
and higher variability among replicates (Fig. 3b).
To assess whether the differential enrichment in his-
tone modifications was local and specific of the regu-
lated exons, or rather affected more extensive regions of
the gene, we analyzed the distribution of epigenetic
marks in the closest upstream and downstream exons
that our method did not identify as differentially in-
cluded (Methods). This defines a ‘not regulated -regu-
lated - not regulated’ exon triplet. Differential chromatin
profiles were calculated within 800 bp windows from the
center of the exons. The results showed that the enrich-
ment in chromatin signals does not extend to the
flanking exons and it is, therefore, specific of the differ-
entially included exons (Figs. 3c–f ). This confirms a sig-
nificant positive association between exon inclusion and
local levels of H3K9ac, H3K27ac, H3K4me3, and CTCF
binding.
R3. Promoter-like histone marks and exon inclusion
While the results above do indicate a significant associ-
ation between a number of histone modifications and
exon inclusion, the effect is certainly weak. This could
reflect a general, but weak, effect of histone modification
on most differentially included exons, or alternatively, a
strong effect only on a subset of them. To investigate
the two alternatives, we performed k-means clustering
on the sets of more and less included exons, based on
the levels of the five chromatin features that we found
significantly associated with differential exon inclusion.
After k-means optimization, the data were partitioned in
four clusters of different signal profiles and each exon
was assigned to the cluster with the nearest mean (Fig. 4,
Methods). As expected ‘more included’ and ‘less in-
cluded’ exons generated similar but mirrored clusters.
The k-means clustering shows clearly that while the
majority of differentially included exons do not show
differences in the levels of the monitored histone mod-
ifications between cell pairs, a subset of 4 % of all dif-
ferentially regulated exons (100 exon comparisons)
exhibits co-occurrence of large differential levels of
H3K9ac, H3K27ac, and H3K4me3 associated with dif-
ferential exon inclusion. Surprisingly, for the clusters
that exhibit a change in the differential level of histone
modifications, this change is always concordant with the
direction of the inclusion level change (Fig. 4, Additional
file 4). This was not the case when performing clustering
Fig. 2 Differentially spliced exons in cell lines. a Inclusion range of regulated exons. The inclusion range of an exon is defined as the difference
between the maximum and the minimum inclusion observed for that exon across the cell lines investigated. Exons are sorted by inclusion range.
b Distribution of the inclusion level of regulated (AS) and non-regulated exons (notAS) across all the cell lines used
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with the histone modifications levels in the downstream
constitutive exons (Additional file 1: Figure S3).
Since these marks are known signatures of active pro-
moters, we will refer to this subset of exons as ‘pro-
moter-like’ exons. These 100 exon comparisons are
distributed across all cell-line pairs considered here
(Additional file 1: Table S5) and they correspond to a
total of 70 unique exons, as some of these exons appear
in multiple comparisons. Principal Component Analysis
(PCA) reinforced the hypothesis that these exons have
peculiar features regarding histone modifications. Indeed
PCA based on the differential histone modification levels
clearly separates the core set of non-‘promoter-like’
exons, the histone modifications levels of which is im-
mune to splicing changes, from the ‘promoter-like’ exons,
which spread in all directions towards the periphery of the
PCA projection (Additional file 1: Figure S4).
To further validate these findings, we compared K562
and NHEK, an ENCODE Tier 2 cell line that had not
been previously used in our analysis. Out of the 70
exons above, 22 are differentially included between these
two cell lines. In two cases, no change in histone modifi-
cation levels could be detected. In 17 of the remaining
20 (85 %), the direction of the differential inclusion is
consistent with the direction of the total differential
levels of H3K9ac, H3K27ac, and H3K4me3 (Additional
file 1: Figure S5), while only in three cases (15 %) exon
inclusion and histone modification levels change in op-
posite directions. With the same rationale, we compared
NHEK with the other cell lines used in our analysis
Fig. 3 Enrichment of chromatin epigenetic marks on regulated exons. a Differential signals (log2, Y-axis) for ‘more included’ (blue) or ‘less in-
cluded’ (red) exons from the seven cell pairs used, are represented for 11 ChIPSeq datasets corresponding to different epigenetic marks, CTCF,
and input DNA (control). The boxplots correspond to the distribution of the average differential signal over the length of each regulated exon.
Wilcoxon rank-sum tests with Bonferroni correction were calculated for the two distributions, significance levels are indicated: * (0.05 > P > 0.01),
** (0.01 > P > 0.001), *** (0.001 > P). CTCF, H3K9ac, H3K4me3, and H3K27ac have significantly higher signal in ‘more included’ than in ‘less included’
exons, while input DNA control shows the opposite trend. b Validation of H3K9ac enrichment over H3 by ChIP. Average and standard deviation
of log2 of the fold change in H3K9ac signal over total H3 signal in regulated (alternative) and constitutive exons from four different genes. Values
are from three independent replicates. White bars in the lower panel represent inclusion level ratios between the two cell lines for the regulated
exons, as determined by RNASeq. A general association between exon inclusion and higher levels of H3K9 acetylation is observed. c–f Differential
ChIPSeq signals (average and standard error of the mean) for CTCF, H3K9ac, H3K27ac, and H3K4me3 are represented for ‘more included’ exons
(blue) and ‘less included’ exons (red) in a 800 bp-window around the middle of the regulated exon (AS) and flanking not regulated (notAS)
upstream (left) and downstream (right) exons. Significance levels are indicated by * (0.05 > P > 0.01), ** (0.01 > P > 0.001), *** (0.001 > P), and ns
(P > 0.05). Differential accumulation of marks is generally specific of regulated exons
Curado et al. Genome Biology  (2015) 16:236 Page 5 of 16
(Gm12878, HelaS3, Huvec, HepG2) and expanded our
validation to 40 out of 47 different exons tested
(Additional file 1: Table S6). Across all comparisons
we obtained 73 % of correct prediction, with a me-
dian validation rate of 71 %.
R4. Characterization of ‘promoter-like’ exons
We thus proceeded to further characterize the subset of
‘promoter-like’ exons. We merged the 100 ‘promoter-
like’ exon comparisons from the more-included and
less-included groups, retaining the association with the
pair of cell lines where they were identified as differen-
tially included. For each exon comparisons we then have
one exon associated with two cell lines: C-higher (the
cell line in which the exon is more included) and C-
lower (the cell line in which it is less included). For a list
of all the ‘promoter-like’ exons and the corresponding
C-higher and C-lower cell lines, see Additional file 1:
Table S7.
Compared to the rest of regulated exons, ‘promoter-
like’ exons are included at particularly low levels, with a
median inclusion level of 0.32 and 0.07 in ‘C-higher’ and
Fig. 4 K-means clustering based on epigenetic signatures of regulated exons. a, b boxplots represent differential ChIPSeq signal for more
included (a) and less included (b) exons. Each square represents one group of exons identified by K-means clustering. The number of
exons present in each cluster is indicated to the left of each cluster. Three clusters of exons show strong differential signal for H3K9ac,
H3K27ac, and H3K4me3 in the direction of the inclusion level change. These exons were called ‘promoter-like’ exons due to the nature of
these histone modifications
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‘C-lower’ cell lines, respectively (see exon inclusion dis-
tribution in Additional file 1: Figure S6), in comparison
with 0.54 and 0.23 for the non-‘promoter-like’ regulated
exons (Fig. 5a). To assess whether low inclusion levels
are a characteristic of ‘promoter-like’ exons, or a conse-
quence of our measurements restricted to human cell
lines, we used 1,500 RNASeq samples from the GTEx
project [32] to estimate exon inclusion levels of the set
of regulated exons in human tissues. We found that also
in human tissues, ‘promoter-like’ exons exhibit signifi-
cantly lower levels of inclusion that regulated non-‘pro-
moter-like’ exons (Additional file 1: Figure S7).
‘Promoter-like’ exons are characterized by additional
promoter-associated features when compared to the
rest of regulated exons. First, they are enriched in
binding sites, both when considering sequence motifs
(Additional file 1: Tables S8 and S9), and accumulation of
Transcription Factor (TF) ChIPSeq reads. Indeed, we
found that 15 out of the 32 TF analyzed have significantly
more accumulation of reads in C-higher than in C-lower
cell lines, while none displays the opposite trend (Fig. 5b
and Additional file 1: Figure S9). Among the enriched
transcription factors is Brg1, which together with Brm is
one of the two ATPases of the chromatin remodeling
complex SWI/SNF, and it has been shown to interact with
the splicing machinery [33] (Additional file 1: Figure S9).
Second, they are enriched in DNase I hypersensitive sites
(DHS) in C-higher cell lines (Fig. 5c). DHS generally mark
cis-regulatory elements and are indicative of open, more
accessible chromatin. The difference in DHS signal is
limited to the regulated exons and does not expand
to the flanking constitutive ones (Fig. 5c). All
Fig. 5 Characterization of “promoter-like” exons. a Exon inclusion levels in C-higher (yellow) and C-lower (blue) cell lines in “promoter-like” and
non “promoter-like” exons. b Transcription factors binding enrichment significance in C-higher over C-lower cell lines. Bonferroni corrected –
log10(p-value) of the enrichment is represented for all the transcription factors tested. All the transcription factors had higher signal in C-higher
(orange). No transcription factor was found enriched on C-lower cell lines in “promoter-like” exon, thus there is no blue dot represented on the
graph. Solid colors represents significant enrichments (p < 0.05) (c-d) DNase I sensitivity and RNA polymerase II signals in promoter-like exons in
C-higher and C-lower cell lines. Signals are represented for regulated (AS) and flanking non-regulated (notAS) exons. For input relative to panel
(d) see Additional file 1: Figure S11
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differentially regulated exons show a similar but
weaker enrichment (Additional file 1: Figure S9). Third,
‘promoter-like’ exons in C-higher also show a clear enrich-
ment of RNA Polymerase II signal (Fig. 5d).
All these promoter associated features in ‘promoter-
like’ exons could suggest that these exons actually over-
lap un-annotated TSS - in which case, elevated levels of
H3K9ac, H3K27ac, and H3K4me3 could simply reflect
the action of transcription, and be unrelated to exon in-
clusion. To rule out this possibility, we analyzed the
number of CAGE tags (sequence tags that target specif-
ically the 5’ end of transcripts [34]) mapping to ‘pro-
moter-like’ exons, and find it marginal when compared
to the level in annotated TSS (Fig. 6a). We also found
no significant difference in the distribution of upstream
and downstream junction inclusion reads (RNASeq
reads that connect two neighboring exons), further con-
firming that ‘promoter-like exons’ are indeed ‘bona fide’
exons, and do not represent, as a bulk, un-annotated
TSSs (Fig. 6b).
R5. Proximity to the promoter and exon inclusion
In spite of not being promoters themselves, ‘promoter-
like’ exons are significantly closer to the annotated TSSs
when compared to the rest of differentially included
exons (Fig. 7a), and many of them are second exons of
the transcript, with their upstream exon beginning at the
TSS itself. This explains the enrichment of DHS and Pol
II signals in the non-regulated exons upstream of ‘pro-
moter-like exons’ (Figs. 5c, d) - albeit these enrichments
are not significantly different between C-higher and C-
lower cell lines, in contrast to the enrichments in the
‘promoter-like’ exons. Moreover, analyzing clusters of
CAGE tags, which are assumed to indicate annotated or
un-annotated TSS, we observed alternative TSS usage
for ‘promoter-like’ exons between cell lines (Fig. 7b). We
found that in 45 of the 100 ‘promoter-like’ exon
comparisons, the active TSS closest to the exon is closer
in the C-higher cell line than in the C-lower cell line,
while in only six exon comparisons is the other way
around (Fig. 7b, c). For eight exon comparisons we
found CAGE clusters within the exonic region, suggest-
ing that these exons could indeed correspond to new,
un-annotated TSSs. This could explain the significant
CAGE enrichment occupancy in ‘promoter-like’ exons
when comparing C-higher and C-lower cell lines
(Fig. 6a). Figure 7d shows an example of an exon with
higher inclusion level in Hela than in Gm1278 and with
a closer active TSS being used only in the cell line of
higher inclusion.
These results suggest that regulated enrichment of his-
tone modifications and other promoter-associated fea-
tures in ‘promoter-like’ exons could be the consequence
of the physical proximity between these exons and real
promoters. Transcription activating histone modifica-
tions would thus be ‘co-opted’ to participate also in the
regulation of inclusion of ‘promoter-like’ exons. To fur-
ther test this hypothesis, we analyzed genome-wide
Chromatin Interaction Analysis with Paired-End-Tag se-
quencing data (ChIA-PET [35]) that has been used to
map long-range chromatin interactions. It was recently
shown that some internal exons loop and physically
interact with promoter and enhancers, and for this rea-
son display ‘promoter-like’ or ‘enhancer-like’ chromatin
marks, and are enriched for co-transcriptional splicing
[36]. These datasets are available only for Hela and K562
and therefore we could only analyze a fraction of the
exon comparisons. In ‘promoter-like’ exons we found
enriched ChIA-PET signal in C-higher than C-lower cell
lines (Fig. 7e) in a fashion independent of the distance
between the TSS and the exon itself (Fig. 7f ). Since these
ChIA-PET datasets target RNA polymerase II with un-
phosphorylated ser2, found in the transcription pre-
initiation complex and marking gene promoters [37],
Fig. 6 ‘Promoter-like’ exons are not used as TSS. a Gene expression levels of exons in C-higher and C-lower conditions measured using CAGE tags.
Distributions are given for ‘bona-fide’ annotated TSSs and for ‘promoter-like’ exons location. Significance levels are indicated by
* (0.05 > P > 0.01), ** (0.01 > P > 0.001), *** (0.001 > P), and ns (P > 0.05). b Distribution of RNASeq junction reads in promoter like exons.
Signals are represented for ‘promoter-like’ exons in C-higher and C-lower conditions. Significance levels are indicated by * (0.05 > P > 0.01),
** (0.01 > P > 0.001) and ‘ns’ (P > 0.05)
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Fig. 7 (See legend on next page.)
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this increase of signal should indicate increase looping
and interaction between ‘promoter-like’ exons and TSSs.
As a control, we did not find ChIA-PET signal enrich-
ment in the set of all regulated exons (Additional file 1:
Figure S10). Figure 7g shows a ‘promoter-like’ exon
more included in Hela than in K562, exhibiting local
peaks of DNase I, RNA Pol II, H3K9ac, H3K27ac, and
H3K4me3 in Hela, but not in K562. The exon also
shows ChIA-PET tags only in Hela cells.
When analyzing individual ChIA-PET links, we found
that 94 % of the ‘promoter-like’ exons have at least one
interaction with the un-phosphorylated pol II, in the C-
higher cell line. This percentage is 68 % in the C-lower
cell line, considering only the cell lines where we have
data available. Genomic connections detected through
ChIA-PET are not necessarily distal. To assess whether
linear proximity in the genome could also explain the
promoter like features of this set of exons, we used chro-
matin segmentation tracks produced by the ENCODE
project (chromHMM [38]). These genome segmenta-
tions represent broad epigenomic domains, reflecting
specific combinations of histone modifications and other
chromatin features. Although the resolution of the
chromHMM segmentations is limited, we found that for
about 40 % of the ‘promoter-like’ exon comparisons the
exon is located in a chromatin state that extends all the
way to the closest used TSS, both in the C-higher and
C-lower cell lines, which would indicate linear proximity
in the genome.
Linear and/or spatial proximity to active promoters ex-
plains the enrichment in histone modifications in in-
cluded ‘promoter-like’ exons, but it does not necessarily
show that there is a mechanistic connection between
exon inclusion and levels of histone modifications. In
fact, we found a positive correlation for these three his-
tone marks between the levels at the TSS and at the
exon, consistently higher and only significant (P value
<0.01) in C-higher cell lines (Additional file 1: Table
S10). However, while accumulation of the marks is
generally higher in C-higher than C-lower cell lines,
both at the TSS and at the exon, the difference in the
levels of the histone modifications between C-higher and
C-lower cell lines is much larger at the exons than at the
TSS (P value <2.2e-7 (Fig. 7h). This strongly suggests
that the enrichment of chromatin marks concomitant
with inclusion in ‘promoter-like’ exons it is not a mere
consequence of proximity to the promoter, but that it is
mechanistically connected to the splicing of these exons.
Discussion
Regulated alternative splicing is assumed to contribute
to cell type identity and methods have been developed
which are able to predict tissue specific exon inclusion
with high accuracy [39]. In our analysis, we found a rela-
tively small number of human exons (about 3 % of all
exons) exhibiting regulated inclusion in a panel of hu-
man cell lines. This cannot be attributed to insufficient
sampling by RNASeq, since ENCODE cell lines are se-
quenced in replicates at very high depth of coverage
(around 240 M reads per sample). On the other hand,
the diversity of biological samples used is certainly re-
duced, and cell lines are known to exhibit peculiar biol-
ogy [40]. While regulated splicing, therefore, is likely to
be more widespread than detected here, our results
could also suggest that the contribution of splicing regu-
lation to defining cell type identity is exerted chiefly
through a relatively small, but well defined, set of exons.
Recent results have unveiled that pre-mRNA splicing
occurs predominantly co-transcriptionally, thus provid-
ing a framework in which chromatin and transcription-
related factors interact with the pre-mRNA processing
machinery. However, among most exons with regulated
inclusion we found in general, little direct association
between differential inclusions and histone modifica-
tions. While these results are not fully unexpected, since
splicing factors are likely to be the main players in spli-
cing regulation, they somehow in contrast with reports
of histone modifications influencing splicing outcomes
(See figure on previous page.)
Fig. 7 Relationship between promoter and ‘promoter-like’ exons. a Distribution of the distance (in nucleotides) between annotated TSS of
‘promoter-like’ and non-‘promoter-like’ exons. b Distribution of the distance (in nucleotides) between ‘promoter-like’ exons and the nearest active
TSS in C-higher and C-lower cell lines. c Proportion of ‘promoter-like’ exons in which the active TSS is closer in C-higher than in C-lower cell lines,
in C-lower than in C-higher cell lines, and at the same distance in C-higher and C-lower cell lines. The total number of exons displaying differences
in TSS usage is 51. d USCS Genome browser view of the DENND3 gene, that contains a ‘promoter-like’ exon (in red) more included in Hela (0.91) than
in Gm12878 cells (0.75). Genomic tracks for CAGE, DNase I, and ChIPSeq of H3K9ac, H3K27ac, andH3K4me3 levels are displayed. The CAGE
signal corresponding to the alternative active promoter, used in Hela, is marked with a red arrow. e ChIA-PET signal in ‘promoter-like’
exons in C-higher and C-lower cell lines. Signals are represented for regulated (AS) and flanking non-regulated (notAS) exons. Significance
levels are indicated by * (0.05 > P > 0.01), ** (0.01 > P > 0.001), *** (0.001 > P), and ns (P > 0.05). f ChIA-PET in ‘promoter-like’ exons separated in bins
according to their distance to the TSS. Significance levels are indicated by * (0.05 > P > 0.01), ** (0.01 > P > 0.001), *** (0.001 > P), and ns (P > 0.05).
g USCS Genome browser view of the P4HA1 gene, that contains an exon (in red) more included in Hela (0.34) than in K562 (0.21) cells.
Genomic tracks for DNase I, ChIA-PET, and ChIPSeq of Pol II, H3K9ac, H3K27ac, and H3K4me3 are displayed. The ChIA-PET signal, specific
of Hela cells, is marked with a blue arrow. h H3K4me3, H3K9ac, and H3K27ac levels on ‘promoter-like’ exons and at the corresponding
closest active TSS. The fold-change between the ChIPSeq signal in C-higher and C-lower is significantly higher (P value <2.2e-7) in the
exon than in the TSS for all histone modifications considered
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through recruitment of splicing factors and through the
modulation of RNA Pol II dynamics. Indeed, previous
work linked high H3K9ac levels in the NCAM gene with
fast elongating RNA Pol II and skipping of a specific
exon [41]. High levels of H3K36me3 or H3K27me3
along the FGFR2 were correlated with the regulation of
a mutually exclusive alternative splicing event [10]. In
these cases, however, changes in histone modifications
appear to spread over large regions covering the whole
gene, while here we explicitly explored chromatin modi-
fications local to the exons. More importantly, in our
work we investigated only direct effects acting independ-
ently, and we ignored the role of high order interactions
between different histone modifications and other ele-
ments of chromatin structure. These could actually con-
figure a quite complex histone-based splicing regulatory
code. Furthermore, we focused specifically in complete
exon skipping events, and ignored other types of splicing
events such as alternative splice site usage. In this re-
gard, Tilgner et al. [21] found that nucleosome occu-
pancy may contribute more strongly to the definition to
the 3’ splice site. If so, histone modifications would also
be expected to play a major role in the regulation of al-
ternative 3’ splice sites.
While we did not found evidence for a general direct
effect of chromatin structure in exon inclusion, we did
identify a subgroup of regulated exons (about 4 % of all
regulated exons) for which co-occurrence of H3K9ac,
H3K27ac, and H3K4me3, histone modifications typically
associated to promoters, strongly correlate with exon
usage levels. This association is not biased by our discov-
ery approach, since we replicated it in cell line compari-
sons that were not part of the training set. These
‘promoter-like’ alternative exons appear predominantly
in low abundance isoforms, but in which, a significant
increase in the density of histone modification correlates
with an increase in the levels of exon inclusion. These
observations suggest that chromatin architecture may
play a more prominent role in the regulation of exon in-
clusion, under conditions of weak splice site recognition.
We further related the accumulation of these histone
modifications in highly included exons with higher occu-
pancy of RNA Polymerase II. Accumulation of RNA
Polymerase II has been linked to exon inclusion [42, 43],
associated with slower Pol II kinetics and consequently
additional opportunities for splice site recognition before
competing sites come into play [44]. However we also
found higher inclusion of ‘promoter-like’ exons in states
of open chromatin, as measured by DNase I. This obser-
vation is somehow in contrast with previously proposed
models linking closed chromatin and slower transcription
elongation with increased exon inclusion [11, 45–47].
In particular for H3K9ac, previous studies reported a
correlation between accumulation of this mark along the
whole gene body (NCAM) and skipping of a specific alter-
native exon [47].
We also found that ‘promoter-like’ exons, while no
promoters themselves, they are, on average, closer to
TSS and enriched by ChIA-PET tags associated with
RNA Polymerase II. Thus, we hypothesize that, in these
exons, splicing regulation is mediated by the promoter,
either by formation of a DNA loop with the exon and
helping chromatin marking and transcription factor
binding extending from the TSS to the alternative exon,
or by differential splice site pairing when an alternative
TSS generates an alternative first exon (Fig. 8). Recent
work exploring the three-dimensional (3D) structure of
the genome reported physical links between internal
exons and their associated promoter or enhancers.
These results argue for an interplay between 3D genome
organization and alternative splicing regulation and war-
rant the systematic analysis of these associations in fu-
ture studies using conformation capture technologies
[48]. An alternative interpretation relies on the fact that
H3K9ac, H3K27ac, H3K4me3, and DNase hypersensitive
on ‘promoter-like’ exons simply reflect open chromatin
on these exons. It is conceivable that binding of factors
facilitated by the opening of chromatin influence splice
site recognition either directly through their effects on
splicing factor recruitment or through effects on RNA
Pol II elongation - a mechanism resembling promotion
of exon inclusion by CTCF [13].
Conclusion
In summary, our work sheds light on functional connec-
tions between chromatin structure and pre-mRNA pro-
cessing, establishing associations between epigenetic
marks and differential exon inclusion and suggesting a
role for promoter-like regions and 3D genome architec-
ture in the regulation of the alternative splicing of cer-
tain exons. We specifically propose that in exons that
are proximal to active promoter regions (either in linear
or 3D space), open chromatin promotes exon inclusion,
maybe by facilitating the recruitment of splicing factors.
However, we want to stress that through our analysis we
are unable to uncover the direction of the causation, and
while histone modifications have been proposed to pro-
mote splicing, results have also been obtained suggesting
that splicing can promote modification of histones by
enhancing the recruitment of chromatin remodeling fac-
tors [49]. Further research will be needed to work out
their detailed molecular mechanisms behind these
observations.
Methods
Alternatively skipped exon calling
Using the gencode [50] v15 annotation we determined
all exons that are
Curado et al. Genome Biology  (2015) 16:236 Page 11 of 16
1. internal in all transcripts they appeared in
2. not overlapped by any non-identical exon
3. between 50 and 450 bps long
4. at least 600 nts away from the respective annotated
TSS or TTS
5. surrounded by AG-GT splice sites
6. located on chromosomes 1–22 and X
For the remaining exons, a 2 × 2 table was constructed
containing junction inclusion reads and junction exclu-
sion reads in the two cell types (cell1 and cell2) retaining
only the exons with a minimum of 1 junction inclusion
read in cell1 and 1 exclusion read in cell2 or vice versa.
For every cell pair, two one-sided Fisher tests were run
and corrected for multiple testing in the Benjamini-
Hochberg sense, resulting in three disjoint sets of exons:
1. exons that are significantly more included in cell1
(which will be referred to as ‘more included’, even
though the choice of the direction from cell1 to
cell2 is clearly arbitrary)
2. exons that are significantly less included in cell1
(which will be referred to as ‘less included’)
3. exons whose inclusion is not significantly changed
between the two cell types (which will be referred to
as ‘notAS exons’ for the sake of conciseness and
clarity, although ‘non-significant AS exons’ would be
more correct)
From the set of more and less included exons, we fur-
ther selected the exons that met the following criteria:
i. the expression of the gene containing the exon
did not change more than 10-fold between cell1
and cell2. To measure gene expression, we used
CAGE tags mapping to the gene promoter (see
below)
ii. at least 75 % of all positions in a 900 bp window
around the acceptor were uniquely mappable for
36mers (see below)
iii. the inclusion levels of the exon changed by at least
0.1 or two-fold between the two cell lines
Fig. 8 Models linking promoter activity with inclusion of ‘promoter-like’ exons. Looping model (a): physical interactions between TSS and
the genomic region corresponding to the alternative exon facilitates exon inclusion (left), while absence of such interactions leads to
more skipping of ‘promoter-like’ exons (pink). Alternative TSS model (b): the activation of an alternative TSS in the proximity of the
genomic region corresponding to the alternative exon facilitates exon inclusion (left), while the inactivation of the TSS closer to the
‘promoter-like’ exon promotes its skipping
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Genes frequently contained more than one alterna-
tively spliced exon thus defined. In order to avoid gene
specific bias that might be introduced by genes that con-
tribute many alternative exons (as for example, the TTN
gene where 212 exons passed the Fisher test), we chose
only one upregulated and up to one downregulated exon
per gene: The exon with the lowest P value among all
exons for the gene in question.
For non-AS exons a similar procedure was carried out
removing, however, the ‘inclusion changed by at least 0.1
or two-fold’ criterion and choosing the exon per gene
whose estimated inclusion change was minimal among
all non-AS exons of that gene (instead of the exon with
the smallest P value). Additional file 1: Figure S1 illustrates
this approach.
Exon triplets
For each regulated exon and each cell type comparison,
we defined two non-regulated exons: The closest up- and
downstream exon that
 appeared in a transcript together with the alternative
exon
 that showed Benjamini-Hochberg-corrected P value
of 0.05 or greater.
Inclusion level calculation
Inclusion level (IncLevel) is a measure defined to de-
scribe the splicing status of the exons. It is computed
as a function of the reads arguing for the inclusion of




0:5  JIRþ JER
A value of 0 represents a totally excluded exon, while
a value of 1 represents a totally included exon. IDR
(Irreproducible Discovery Rate), a measure widely used
within the ENCODE project to assess reproducibility
between replicates [51], was applied at a level of 0.01
and only the exons passing this filtered were used in the
remaining analysis.
Splice site strength measure
For each exon we used maxEnt [52] in order to calculate
an acceptor score and a donor score and represented the
‘exon strength’ by the sum of these two scores.
Gene expression calculation
We employed ENCODE provided CAGE-clusters fil-
tered by an Hidden Markov Model algorithm (TSS-
HMM) to differentiate between 5’ capped termini of Pol
II transcripts and recapping events, and scored accord-
ing to number of constituent CAGE tags [25].
We associated CAGE-clusters to the closest TSS
within a radius of 100 nucleotides. We computed the ex-
pression of a given gene as the sum of the scores of
CAGE-clusters associated to all genes’ TSSs.
Mappability calculation
Mappability for the hg19 genome was calculated using
the GEM-mapper [53] for 36 bp and 75 bp reads. For
each acceptor in the genome, mappability was calculated
in the direction of transcription.
Exon selection for validation experiments
Out of the exons that had cell type-specific H3K9ac
peaks that co-occurred with high exon inclusion, we se-
lected a total of 12 exons for validation by RT-PCR and
ChIP.
Cell culture, RNA extraction, and RT-PCR analysis
K562 and Hela cells were grown in Dulbecco’s modified
Eagle’s medium (Gibco BRL) supplemented with 10 % of
fetal bovine serum (FBS), penicillin, and streptomycin.
Gm12878 cells were grown in RPMI (Gibco 1640), sup-
plemented with 15%FBS (Gibco BRL), glycine (SEE),
penicillin, and streptomycin.
Total RNA was isolated using Qiagen RNeasy mini
kit and re-suspended in RNAse-free water (Ambion).
DNA digestion was performed using RNase-free DNase
(Promega). DNA-free total RNA (1 μg) was used for RT −
PCR using SuperScript III reverse transcriptase (Invitro-
gen), random hexamers and oligo dT. 5 % of the reaction
was used for real time PCR (Applied Biosystem) together
with the primers (Additional file 1: Table S4) following the
manufacturer’s instructions.
Chromatin immunoprecipitation (ChIP)
Cells were plated at a density of 2 × 105 cells in 75 cm2
flasks and after 48 h of culture, incubated with 1 % (vol/
vol) formaldehyde in culture medium for 10 min at
room temperature. Cells were then washed in cold
phosphate-buffered saline (PBS), harvested, and lysed in
a buffer containing 1 % SDS, 10 mM EDTA, and 50 mM
Tris/HCl pH 8.1, and sonicated in 15 mL tubes with
Bioruptor UCD-200 Diagenode (ultrasonic wave output
power 250 W, 30” on-30” off, 4 × 10’) to yield chromatin
sizes of 150–300 bp. A total of 100 μg of DNA/sample
were used for immunoprecipitation with 5 μg of anti-
H3K9ac rabbit (ab4441), anti-H3 rabbit (ab1791), or
control rabbit IgGs (Sigma-Aldrich). Co-precipitated
DNA was then analyzed by quantitative real time PCR
performed with Sybr Green mix (Applied Biosystem) ac-
cording to the manufacturer’s instructions. The antibody
against total H3 was used for normalization as well
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as a control to exclude the possibility that the effects
observed are caused by differences in nucleosome occu-
pancy. The primers used are listed in the Additional file 1:
Table S1.
Exonic average signal (EAS)
We used ENCODE signal tracks [54] for a given histone
mark (for example, H3K4me3). This signal track repre-
sents a sequencing-depth-normalized read density for
each position on the genome.
 For each exon and cell-line we averaged this signal
over all positions of the exon using bwtool [55], in
order to get a single value representing the
H3k4me3 signal on the exon in the cell type in
question
 We proceeded the same way for all other histone
marks, CTCF, Pol II, Input DNA, DNAse I, different
transcription factors, and ChIA-PET
Differential signal of EAS in two cell lines
 In a cell-type comparison we calculated for each
exon the difference between the EAS in cell type I
and in cell type II
 We then considered the distribution of these
difference values of all exons being studied
 Wilcoxon signed-rank test, with Bonferroni correction
for multiple testing, was used to assess the significance
between the groups of exons
Distribution of exonic average signal (EAS) for C-higher
and C-lower cell-lines
 Using for all 100 exons the C-higher cell line, we
computed a distribution of DNAse I-EAS for C-higher
 Using the C-lower cell line in the same way, we
computed a second distribution for the C-lower cell
line
 These two distributions are shown for DNAseI in
Fig. 5c. Figure 5d shows the same for Pol2. Similarly
in Additional file 1: Figure S8, we show the same for
transcription factors with a significant difference
between C-higher and C-lower. In Fig. 7e, we show
the same for ChIA-PET (using only K562 and
HelaS3, because these are the only cell lines, for
which ChIA-PET is available). In Fig. 7h, we show
the distributions for histone modification levels in
the exons and their closest used TSS
Genomic interactions
Besides the average signal from ChIA-PET experiments
we also quantified the number of interactions found, per
exon, with the un-phosphorylated ser2 polymerase II
using the R package GenomicInteractions [56].
Exon clustering
Alternative spliced exons differentially expressed be-
tween cell lines were partitioned according to their
histone modifications and control levels using a k-
means clustering approach. Unsupervised k-means
clustering was applied to ‘higher included’ and ‘lower
included’ exons separately using the differential sig-
nals of H3K9ac, H3K4me3, H3K27ac, CTCF, and
control, the variables that came out as significant in
Fig. 3. When defining the number of clusters re-
quired, we tried 2, 3, 4, and 5. K = 4 maximized the
number of exons clustered with a clear signal for the
histone modifications we were looking at. Exon com-
parisons falling in cluster 3 and 4 of ‘higher in-
cluded’ exons and in cluster 4 of ‘lower included’
exons were merged in the group of ‘promoter-like
exons’. Each exon comparison was thus composed by
one exon, one cell line with higher inclusion level
(C-higher) and one cell line with lower inclusion
level (C-lower).
Distance to closest annotated TSS
The distance of an exon to the annotated TSS was calcu-
lated by measuring the genomic distance from the first
nucleotide of the exon and the closest TSS from all the
transcripts the exon belongs to.
Distance to closest used TSS
The distance of an exon to the closest used TSS was cal-
culated by finding the closest CAGE-cluster from the
TSS-HMM with a minimum expression value of 1 and
calculating its genomic distance to the studied exon, in
an annotation independent manner.
Binding motifs analysis
A hyper geometric test, with Benjamin-Hochberg P
value correction, was applied to JASPAR CORE 2014
[57] and MEME 4.4 [58] databases looking for en-
richment in binding transcription factor and RNA
binding proteins motifs inside the exons, respectively, in
the ‘promoter-like exons’ versus the remaining differen-
tially included identified exons.
Splicing change in NHEK
NHEK, a cell line not used in the discovery analysis of
the paper, was used for validation of our findings. The
difference in inclusion and in histone modification signal
was calculated between NHEK and K562, Gm12878,
HepG2, HUVEC, and HeLaS3. Only exons with an in-
clusion difference larger than 0.1 and total chromatin
difference larger than 1 were used. Total signal was
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calculated as the sum of H3K27ac, H3K4me3, and
H3K9ac differences.
Exon inclusion in GTEx project
We calculate inclusion levels, as described above, for the
set of all internal exons in the 1,493 postmortem samples
available from the GTEx project. The samples are very
heterogeneous, coming from up to 43 different tissues
from 175 individuals.
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Abbreviations
Bp: base pairs; CAGE: Cap analysis gene expression; ChIA-PET: Chromatin
Interaction Analysis with Paired-End-Tag sequencing; ChIP: chromatin
immunoprecipitation; ChIPSeq: sequencing of chromatin
immunoprecipitation; CTCF: CCCTC-binding factor; DHS: DNase I
hypersensitivity sites; DNA: Deoxyribonucleic acid; ENCODE: Encyclopedia of
DNA Elements; GTEx: Genotype-Tissue Expression project; H3K27ac: H3 lysine
27 acetylation; H3K4me3: H3 lysine 3 trimethylation; H3K9ac: H3 lysine 9
acetylation; IDR: Irreproducible discovery rate; JER: Junction exclusion read;
JIR: Junction inclusion read; mRNA: Messenger ribonucleic acid;
NMD: Nonsense mediated decay; PCA: Principal component analysis;
Pol: Polymerase; PolyA+: Polyadenylated; qPCR: quantitative real-time poly-
merase chain reaction; RNA: Ribonucleic acid; RNASeq: Sequencing of RNA;
RT-PCR: Reverse transcription polymerase chain reaction; TF: Transcription
factor; TSS: Transcription start site; TTS: Transcription termination site.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
All the authors conceived the study and wrote the paper. JC and HT carried
out the data analysis. CI performed the validation experiments. All authors
read and approved the final manuscript.
Description of additional data files
The following additional data files are available with the online version of
the paper. Additional file 1 contains the supplementary figures and tables.
Additional files 2 and 3 contain the set of differentially included exons
selected in all cell pairs used, more and less included exons, respectively.
These files are in bed format and field 4 is the cell pair in which the exon
was identified as regulated. Additional file 4 contains the list of ‘promoter-like’,
also in bed format.
Acknowledgements
Research reported in this publication was supported by the NHGRI award
1U54HG007004, the Spanish Ministerio de Economia y Conocimiento
(MINECO) grant BIO2011-26205 and the ERC/European Community PF7 grant
294653 RNA-MAPS. We acknowledge support of the Spanish Ministry of
Economy and Competitiveness, ‘Centro de Excelencia Severo Ochoa 2013-
2017’, SEV-2012-0208. JC was supported by a SFRH/BD/33535/2008 from the
Portuguese Foundation to Science and Technology. CI was supported by a
La Caixa predoctoral fellowship. Work in JV’s lab was supported by Fundación
Botín, by Banco de Santander through its Santander Universities Global Division
and by Consolider RNAREG, MINECO, and AGAUR. We thank Anshul Kundaje,
Ben Brown, Michael Snyder, Thomas Gingeras, and Alberto Kornblihtt for useful
discussions and access to data, and Romina Garrido for administrative
assistance.
Author details
1Centre for Genomic Regulation (CRG), The Barcelona Institute of Science
and Technology, Dr. Aiguader, 88, 08003 Barcelona, Catalonia, Spain.
2Graduate program in Areas of Basic and Applied Biology, Abel Salazar
Biomedical Sciences Institute, University of Porto, 4099-003 Porto, Portugal.
3Universitat Pompeu Fabra, Dr. Aiguader, 88, 08003 Barcelona, Catalonia,
Spain. 4Department of Genetics, Stanford University, 300 Pasteur Dr.,
Stanford, CA 94305-5120, USA. 5Institució Catalana de Recerca i Estudis
Avançats, Pg Lluis Companys 23, 08010 Barcelona, Catalonia, Spain.
Received: 22 August 2015 Accepted: 5 October 2015
References
1. Kim E, Magen A, Ast G. Different levels of alternative splicing among
eukaryotes. Nucleic Acids Res. 2007;35:125–31.
2. Nilsen TW, Graveley BR. Expansion of the eukaryotic proteome by
alternative splicing. Nature. 2010;463:457–63.
3. Fu XD, Ares Jr M. Context-dependent control of alternative splicing by
RNA-binding proteins. Nat Rev Genet. 2014;15:689–701.
4. Beyer AL, Osheim YN. Splice site selection, rate of splicing, and alternative
splicing on nascent transcripts. Genes Dev. 1988;2:754–65.
5. Kornblihtt AR, de la Mata M, Fededa JP, Munoz MJ, Nogues G. Multiple links
between transcription and splicing. RNA. 2004;10:1489–98.
6. Carrillo Oesterreich F, Preibisch S, Neugebauer KM. Global analysis of
nascent RNA reveals transcriptional pausing in terminal exons. Mol Cell.
2010;40:571–81.
7. Khodor YL, Rodriguez J, Abruzzi KC, Tang CH, 2nd Marr MT, Rosbash M.
Nascent-seq indicates widespread cotranscriptional pre-mRNA splicing in
Drosophila. Genes Dev. 2011;25:2502–12.
8. Ameur A, Zaghlool A, Halvardson J, Wetterbom A, Gyllensten U, Cavelier L,
et al. Total RNA sequencing reveals nascent transcription and widespread
co-transcriptional splicing in the human brain. Nat Struct Mol Biol.
2011;18:1435–40.
9. Tilgner H, Knowles DG, Johnson R, Davis CA, Chakrabortty S, Djebali S, et al.
Deep sequencing of subcellular RNA fractions shows splicing to be
predominantly co-transcriptional in the human genome but inefficient for
lncRNAs. Genome Res. 2012;22:1616–25.
10. Luco RF, Pan Q, Tominaga K, Blencowe BJ, Pereira-Smith OM, Misteli T.
Regulation of alternative splicing by histone modifications. Science.
2010;327:996–1000.
11. de la Mata M, Alonso CR, Kadener S, Fededa JP, Blaustein M, Pelisch F, et al.
A slow RNA polymerase II affects alternative splicing in vivo. Mol Cell.
2003;12:525–32.
12. Roberts GC, Gooding C, Mak HY, Proudfoot NJ, Smith CW. Co-transcriptional
commitment to alternative splice site selection. Nucleic Acids Res.
1998;26:5568–72.
13. Shukla S, Kavak E, Gregory M, Imashimizu M, Shutinoski B, Kashlev M, et al.
CTCF-promoted RNA polymerase II pausing links DNA methylation to
splicing. Nature. 2011;479:74–9.
14. Andersson R, Enroth S, Rada-Iglesias A, Wadelius C, Komorowski J.
Nucleosomes are well positioned in exons and carry characteristic histone
modifications. Genome Res. 2009;19:1732–41.
15. Hon G, Wang W, Ren B. Discovery and annotation of functional chromatin
signatures in the human genome. PLoS Comput Biol. 2009;5:e1000566.
16. Kolasinska-Zwierz P, Down T, Latorre I, Liu T, Liu XS, Ahringer J. Differential
chromatin marking of introns and expressed exons by H3K36me3. Nat
Genet. 2009;41:376–81.
17. Nahkuri S, Taft RJ, Mattick JS. Nucleosomes are preferentially positioned at
exons in somatic and sperm cells. Cell Cycle. 2009;8:3420–4.
18. Schwartz S, Meshorer E, Ast G. Chromatin organization marks exon-intron
structure. Nat Struct Mol Biol. 2009;16:990–5.
19. Spies N, Nielsen CB, Padgett RA, Burge CB. Biased chromatin signatures
around polyadenylation sites and exons. Mol Cell. 2009;36:245–54.
Curado et al. Genome Biology  (2015) 16:236 Page 15 of 16
20. Iannone C, Pohl A, Papasaikas P, Soronellas D, Vicent GP, Beato M, et al.
Relationship between nucleosome positioning and progesterone-induced
alternative splicing in breast cancer cells. RNA. 2015;21:360–74.
21. Tilgner H, Nikolaou C, Althammer S, Sammeth M, Beato M, Valcarcel J, et al.
Nucleosome positioning as a determinant of exon recognition. Nat Struct
Mol Biol. 2009;16:996–1001.
22. Enroth S, Bornelov S, Wadelius C, Komorowski J. Combinations of histone
modifications mark exon inclusion levels. PLoS One. 2012;7:e29911.
23. ENCODE Project Consortium. An integrated encyclopedia of DNA elements
in the human genome. Nature. 2012;489:57–74.
24. ENCODE Project Consortium. A user’s guide to the encyclopedia of DNA
elements (ENCODE). PLoS Biol. 2011;9:e1001046.
25. Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, et al.
Landscape of transcription in human cells. Nature. 2012;489:101–8.
26. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, et al. Alternative
isoform regulation in human tissue transcriptomes. Nature. 2008;456:470–6.
27. Magen A, Ast G. The importance of being divisible by three in alternative
splicing. Nucleic Acids Res. 2005;33:5574–82.
28. Zheng CL, Fu XD, Gribskov M. Characteristics and regulatory elements
defining constitutive splicing and different modes of alternative splicing in
human and mouse. RNA. 2005;11:1777–87.
29. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, et al.
High-resolution profiling of histone methylations in the human genome.
Cell. 2007;129:823–37.
30. Hoffman MM, Buske OJ, Wang J, Weng Z, Bilmes JA, Noble WS.
Unsupervised pattern discovery in human chromatin structure through
genomic segmentation. Nat Methods. 2012;9:473–6.
31. Kundaje A, Kyriazopoulou-Panagiotopoulou S, Libbrecht M, Smith CL,
Raha D, Winters EE, et al. Ubiquitous heterogeneity and asymmetry of
the chromatin environment at regulatory elements. Genome Res.
2012;22:1735–47.
32. Consortium G. The Genotype-Tissue Expression (GTEx) project. Nat Genet.
2013;45:580–5.
33. Zhao K, Wang W, Rando OJ, Xue Y, Swiderek K, Kuo A, et al. Rapid
and phosphoinositol-dependent binding of the SWI/SNF-like BAF
complex to chromatin after T lymphocyte receptor signaling. Cell.
1998;95:625–36.
34. Kodzius R, Kojima M, Nishiyori H, Nakamura M, Fukuda S, Tagami M, et al.
CAGE: cap analysis of gene expression. Nat Methods. 2006;3:211–22.
35. Fullwood MJ, Liu MH, Pan YF, Liu J, Xu H, Mohamed YB, et al. An oestrogen-
receptor-alpha-bound human chromatin interactome. Nature. 2009;462:58–64.
36. Mercer TR, Edwards SL, Clark MB, Neph SJ, Wang H, Stergachis AB, et al.
DNase I-hypersensitive exons colocalize with promoters and distal
regulatory elements. Nat Genet. 2013;45:852–9.
37. Heidemann M, Hintermair C, Voss K, Eick D. Dynamic phosphorylation
patterns of RNA polymerase II CTD during transcription. Biochim Biophys
Acta. 2013;1829:55–62.
38. Ernst J, Kellis M. ChromHMM: automating chromatin-state discovery and
characterization. Nat Methods. 2012;9:215–6.
39. Xiong HY, Alipanahi B, Lee LJ, Bretschneider H, Merico D, Yuen RK, et al.
RNA splicing. The human splicing code reveals new insights into the
genetic determinants of disease. Science. 2015;347:1254806.
40. Lukk M, Kapushesky M, Nikkila J, Parkinson H, Goncalves A, Huber W, et al. A
global map of human gene expression. Nat Biotechnol. 2010;28:322–4.
41. Schor IE, Gomez Acuna LI, Kornblihtt AR. Coupling between transcription
and alternative splicing. Cancer Treat Res. 2013;158:1–24.
42. de la Mata M, Lafaille C, Kornblihtt AR. First come, first served revisited:
factors affecting the same alternative splicing event have different effects
on the relative rates of intron removal. RNA. 2010;16:904–12.
43. Dujardin G, Lafaille C, de la Mata M, Marasco LE, Munoz MJ, Le Jossic-Corcos
C, et al. How slow RNA polymerase II elongation favors alternative exon
skipping. Mol Cell. 2014;54:683–90.
44. Kornblihtt AR, Schor IE, Allo M, Dujardin G, Petrillo E, Munoz MJ. Alternative
splicing: a pivotal step between eukaryotic transcription and translation. Nat
Rev Mol Cell Biol. 2013;14:153–65.
45. Allo M, Buggiano V, Fededa JP, Petrillo E, Schor I, de la Mata M, et al.
Control of alternative splicing through siRNA-mediated transcriptional gene
silencing. Nat Struct Mol Biol. 2009;16:717–24.
46. Saint-Andre V, Batsche E, Rachez C, Muchardt C. Histone H3 lysine 9
trimethylation and HP1gamma favor inclusion of alternative exons. Nat
Struct Mol Biol. 2011;18:337–44.
47. Schor IE, Kornblihtt AR. Playing inside the genes: Intragenic histone
acetylation after membrane depolarization of neural cells opens a path for
alternative splicing regulation. Commun Integr Biol. 2009;2:341–3.
48. Dekker J, Marti-Renom MA, Mirny LA. Exploring the three-dimensional
organization of genomes: interpreting chromatin interaction data. Nat Rev
Genet. 2013;14:390–403.
49. de Almeida SF, Grosso AR, Koch F, Fenouil R, Carvalho S, Andrade J, et al.
Splicing enhances recruitment of methyltransferase HYPB/Setd2 and
methylation of histone H3 Lys36. Nat Struct Mol Biol. 2011;18:977–83.
50. Harrow J, Frankish A, Gonzalez JM, Tapanari E, Diekhans M, Kokocinski F, et
al. GENCODE: the reference human genome annotation for The ENCODE
Project. Genome Res. 2012;22:1760–74.
51. Li JJ, Jiang CR, Brown JB, Huang H, Bickel PJ. Sparse linear modeling
of next-generation mRNA sequencing (RNA-Seq) data for isoform
discovery and abundance estimation. Proc Natl Acad Sci U S A.
2011;108:19867–72.
52. Yeo G, Burge CB. Maximum entropy modeling of short sequence motifs
with applications to RNA splicing signals. J Comput Biol. 2004;11:377–94.
53. Marco-Sola S, Sammeth M, Guigo R, Ribeca P. The GEM mapper: fast,
accurate and versatile alignment by filtration. Nat Methods. 2012;9:1185–8.
54. Hoffman MM, Ernst J, Wilder SP, Kundaje A, Harris RS, Libbrecht M, et al.
Integrative annotation of chromatin elements from ENCODE data. Nucleic
Acids Res. 2013;41:827–41.
55. Pohl A, Beato M. bwtool: a tool for bigWig files. Bioinformatics.
2014;30:1618–9.
56. Harmston N, Ing-Simmons E, Perry M, Baresic A, Lenhard B.
GenomicInteractions: R package for handling genomic interaction data. R
package version 1.0.0. 2014.
57. Sandelin A, Alkema W, Engstrom P, Wasserman WW, Lenhard B. JASPAR: an
open-access database for eukaryotic transcription factor binding profiles.
Nucleic Acids Res. 2004;32:D91–4.
58. Bailey TL, Boden M, Buske FA, Frith M, Grant CE, Clementi L, et al. MEME
SUITE: tools for motif discovery and searching. Nucleic Acids Res.
2009;37:W202–8.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Curado et al. Genome Biology  (2015) 16:236 Page 16 of 16
